TP53 is among the most frequently mutated tumor-suppressor genes in human cancer, with the unique characteristic that p53 proteins expressed from missense mutated or truncated alleles (Onc-p53) acquire emergent oncogenic functions (also termed “gain of function” in the literature), facilitating tumor cell growth, proliferation, and apoptotic evasion (37). Here, TP53 is linked to neoplasm.